Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study-Reference-Cited by-同舟云学术

Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study

Published:2018-11-13 Issue:2 Volume:49 Page:125-135
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Itokawa Norio¹,Atsukawa Masanori¹²,Tsubota Akihito³,Ikegami Tadashi⁴,Shimada Noritomo⁵,Kato Keizo⁶,Abe Hiroshi⁶,Okubo Tomomi¹,Arai Taeang¹,Iwashita Ai-Nakagawa¹,Kondo Chisa²,Mikami Shigeru⁷,Asano Toru⁸,Matsuzaki Yasushi⁴,Toyoda Hidenori⁹^ORCID,Kumada Takashi¹⁰,Iio Etsuko¹¹,Tanaka Yasuhito¹¹,Iwakiri Katsuhiko²

Affiliation:

1. Department of Internal Medicine, Division of Gastroenterology; Nippon Medical School Chiba Hokusoh Hospital; Chiba Japan

2. Department of Internal Medicine, Division of Gastroenterology and Hepatology; Nippon Medical School; Tokyo Japan

3. Core Research Facilities for Basic Science; The Jikei University School of Medicine; Tokyo Japan

4. Department of Internal Medicine, Division of Hepatology and Gastroenterology; Tokyo Medical University, Ibaraki Medical Center; Ibaraki Japan

5. Department of Internal Medicine, Division of Gastroenterology and Hepatology; Otakanomori Hospital; Chiba Japan

6. Department of Internal Medicine, Division of Gastroenterology and Hepatology; Shinmatsudo Central General Hospital; Chiba Japan

7. Department of Internal Medicine, Division of Gastroenterology; Kikkoman General Hospital; Chiba Japan

8. Department of Internal Medicine, Division of Gastroenterology and Hepatology; Tokyo Metropolitan Bokutoh Hospital; Tokyo Japan

9. Department of Gastroenterology; Ogaki Municipal Hospital; Gifu Japan

10. Department of Nursing; Ogaki Women's College; Gifu Japan

11. Department of Virology and Liver Unit; Nagoya City University, Graduate School of Medical Sciences; Aichi Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.13256/fullpdf

Reference31 articles.

1. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward);Dore;J Viral Hepat,2014

2. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;Kiyosawa;Hepatology,1990

3. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection;Kumada;Hepatology,2014

4. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial;Mizokami;Lancet Infect Dis,2015

5. Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis;Kumada;Hepatology,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis;Journal of Gastroenterology;2024-05-10

2. Evaluation of Direct-Acting Antiviral Therapy Efficacy and Post-Treatment Fibrosis with Noninvasive Markers in Patients with Chronic Hepatitis C;Flora the Journal of Infectious Diseases and Clinical Microbiology;2023-12-22

3. Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy;Journal of Infection and Chemotherapy;2022-09

4. Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer;Cancers;2022-05-04

5. Mac‐2‐binding protein glycan isomer predicts all malignancies after sustained virological response in chronic hepatitis C;Hepatology Communications;2022-03-28